本研究使用的成本输入值概述

数据集获取（Figshare）

• 源站标题：Overview of costs input values used in this study.
• DOI：10.1371/journal.pone.0021919.t001
• 发布日期：2011-07-20
• 文件数：1 个
• 文件总体积：5.63 KB
• 源站页面：https://plos.figshare.com/articles/dataset/_Overview_of_costs_input_values_used_in_this_study_/425124

命令行下载

curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/754750"

文件清单

• Table_1.xls（5.63 KB）

文件总体积 5.63 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

The perspective of the Hlabisa Treatment and Care Programme was chosen. Costs are stratified by CD4+ count at antiretroviral therapy (ART) initiation, and include costs of diagnostic testing, ART provision, treatment of opportunistic infections, outpatient visits, and inpatient days. In addition, some costs were included for patients seeking care but not (yet) eligible for ART: (1) 1,165 US$ per year for patients with CD4+ counts of 201–350 cells/µl, reflecting costs of testing and treatment of opportunistic infections; and (2) 104 US$ for patients with CD4+ cell counts of >350 cells/µl reflecting costs of CD4+ cell count monitoring. Furthermore, a one-time cost of dying of 1,197 US$ was included for each HIV-related death, irrespective of being on treatment and CD4+ count at initiation.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0021919.t001（source: https://plos.figshare.com/articles/dataset/_Overview_of_costs_input_values_used_in_this_study_/425124）。